 HACKENSACK, NJ ACCESSWIRE January 5, 2021 Champions Oncology, Inc. NASDAQ:CSBR, a leading global oncology technology company that is transforming drug discovery and development through data-driven research strategies, announced today the expansion of its SaaS program, Lumin Bioinformatics. Since its launch, Champions has been adding to the data and functionality housed within Lumin, which now features 20,000 datasets including rare and valuable quantitative phospho-proteomics. 